Your browser doesn't support javascript.
loading
Doxazosin and erlotinib have anticancer effects in the endometrial cancer cell and important roles in ERα and Wnt/ß-catenin signaling pathways.
Karaca, Büsra; Bakir, Elçin; Yerer, Mükerrem Betül; Cumaoglu, Ahmet; Hamurcu, Zuhal; Eken, Ayse.
Afiliação
  • Karaca B; Hakan Çetinsaya Good Clinical Practice and Research Center, Erciyes University, Kayseri, Turkey.
  • Bakir E; Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Erciyes University, Kayseri, Turkey.
  • Yerer MB; Department of Pharmacology, Faculty of Pharmacy, Erciyes University, Kayseri, Turkey.
  • Cumaoglu A; Department of Biochemistry, Faculty of Pharmacy, Erciyes University, Kayseri, Turkey.
  • Hamurcu Z; Department of Medical Biology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
  • Eken A; Betül-Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey.
J Biochem Mol Toxicol ; 35(11): e22905, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34463000
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Doxazossina / Receptor alfa de Estrogênio / Beta Catenina / Via de Sinalização Wnt / Cloridrato de Erlotinib / Antineoplásicos Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Doxazossina / Receptor alfa de Estrogênio / Beta Catenina / Via de Sinalização Wnt / Cloridrato de Erlotinib / Antineoplásicos Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article